Injectable Modified Sodium Alginate Microspheres for Enhanced Operative Efficiency and Safety in Endoscopic Submucosal Dissection.
Luzhan HuangYong-Chao JiangPengcheng ZhangMuhan LiBingrong LiuKeyong TangPublished in: Biomacromolecules (2024)
Endoscopic submucosal dissection (ESD) is an effective method for resecting early-stage tumors in the digestive system. To achieve a low injection pressure of the injected fluid and continuous elevation of the mucosa following injection during the ESD technique, we introduced an innovative injectable sodium-alginate-based drug-loaded microsphere (Cipro-ThSA) for ESD surgery, which was generated through an emulsion reaction involving cysteine-modified sodium alginate (ThSA) and ciprofloxacin. Cipro-ThSA microspheres exhibited notable adhesiveness, antioxidant activity, and antimicrobial properties, providing a certain level of postoperative wound protection. In vitro cell assays confirmed the decent biocompatibility of the material. Lastly, according to animal experiments involving submucosal elevation of porcine colons, Cipro-ThSA microspheres ensure surgically removable lift height while maintaining the mucosa for approximately 246% longer than saline, which could effectively reduce surgical risks while providing sufficient time for operation. Consequently, the Cipro-ThSA microsphere holds great promise as a novel submucosal injection material, in terms of enhancing the operational safety and effectiveness of ESD surgery.
Keyphrases
- endoscopic submucosal dissection
- tissue engineering
- wound healing
- minimally invasive
- early stage
- coronary artery bypass
- surgical site infection
- ultrasound guided
- molecularly imprinted
- randomized controlled trial
- body mass index
- hyaluronic acid
- systematic review
- drug delivery
- staphylococcus aureus
- single cell
- patients undergoing
- high throughput
- pseudomonas aeruginosa
- cell therapy
- stem cells
- percutaneous coronary intervention
- acute coronary syndrome
- risk assessment
- cystic fibrosis
- living cells
- adverse drug
- artificial intelligence
- high resolution
- simultaneous determination
- tandem mass spectrometry